##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 132 Download : 75

##plugins.themes.academic_pro.article.main##

Abstract

Diabetes mellitus (DM) is one of the most common metabolic diseases, and the number of cases has increased worldwide. According to the International Diabetes Federation (IDF), the number of patients with diabetes will increase from 387 million in 2014 to 592 million in 2035. With a global prevalence of 8.3%, DM represents a worldwide problem [1]. Diabetic neuropathies are the most prevalent chronic complications of diabetes. This heterogeneous group of conditions affects different parts of the nervous system and presents with diverse clinical manifestations. Chronic sensorimotor DPN is the most common form of DN.3-5 A major symptom in DN patients is pain arising as a direct consequence of abnormalities in the peripheral somatosensory system in people with diabetes. 4 The symptoms can be present as severe numbness, paresthesia, or hyperesthesia, however, DPN may be asymptomatic in about 50% of patients 5 and as the DPN progresses, the painful symptoms usually disappear although they have a substantial impact in quality of life (QoL).

Keywords

Diabetic Peripheral Neuropathy type 2 diabetes mellitus quality of life

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Najmutdinova D.K, Khudaybergenova D.H, Nizometdinova U.J, & Hidoyatov K.H. (2022). “To Study the Quality of Life of Patients with Type 2 Diabetes Complicated by Polyneuropathy”. Texas Journal of Medical Science, 15, 17–23. https://doi.org/10.62480/tjms.2022.vol15.pp17-23
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Albers JW, Pop-Busui R. Diabetic neuropathy:mechanisms, emerging treatments, and subtypes. Curr Neurol Neurosci Rep 2014;14: 473
  2. Callaghan BC, Kerber KA, Lisabeth LL, et al. Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy. JAMA Neurol 2014;71:1143–1149
  3. Dyck PJ, Albers JW, Andersen H, et al.; Toronto Expert Panel on Diabetic Neuropathy. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev 2011;27: 620–628
  4. Malik RA, Veves A, Tesfaye S, et al.; Toronto Consensus Panel on Diabetic Neuropathy. Small fibre neuropathy: role in the diagnosis of diabetic sensorimotor polyneuropathy. Diabetes Metab Res Rev 2011;27:678–684
  5. Smith AG, Singleton JR. Diabetic neuropathy. Continuum (Minneap Minn) 2012;18:60–84
  6. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001;24:1448–1453
  7. Asghar O, Petropoulos IN, Alam U, et al. Corneal confocal microscopy detects neuropathy in
  8. subjects with impaired glucose tolerance. Diabetes Care 2014;37:2643–2646
  9. Bongaerts BW, Rathmann W, Heier M, et al. Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: the KORA F4 study. Diabetes Care 2013;36:1141–1146
  10. Im S, Kim SR, Park JH, Kim YS, Park GY. Assessment of the medial dorsal cutaneous, dorsal sural, and medial plantar nerves in impaired glucose tolerance and diabetic patients with normal sural and superficial peroneal nerve responses. Diabetes Care 2012;35:834–839
  11. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A; KORA Study Group. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 2008;31:464–469
  12. Bernardi L, Spallone V, Stevens M, et al.; Toronto Consensus Panel on Diabetic Neuropathy. Investigation methods for cardiac autonomic function in human research studies.Diabetes Metab Res Rev 2011;27:639–653
  13. Kempler P, Amarenco G, Freeman R, et al.; Toronto Consensus Panel on Diabetic Neuropathy. Gastrointestinal autonomic neuropathy,erectile-, bladder- and sudomotor dysfunction in patients with diabetes mellitus: clinical impact,assessment, diagnosis, and management. Diabetes Metab Res Rev 2011;27:665–677
  14. Spallone V, Ziegler D, Freeman R, et al.; Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011;27: 639–653
  15. Tesfaye S, Boulton AJ, Dyck PJ, et al.; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions,
  16. diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33:2285–2293
  17. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015;14:162–173
  18. Bril V, England JD, Franklin GM, et al.; American Academy of Neurology; American Asociation of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Evidence-based guideline:
  19. treatment of painful diabetic neuropathy–report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation. Muscle Nerve 2011;43:910–917
  20. Diabetes Control and Complications Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med 1993;329:977–986
  21. IFD. International Diabetes Federation: IDF.org; 2015. Available from: http://www.idf.org/
  22. Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J diabetes investig. 2014; 5(6):714-21.
  23. Lyrakos GN, Arvaniti C, Smyrnioti M, Kostopanagiotou G. P03-561 - Translation and validation study of the depression anxiety stress scale in the greek general population and in a psychiatric patient’s sample. European Psychiatry. 2011; 26(null):1731.